Context TherapeuticsCNTX
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 37 institutions reported holding Context Therapeutics Inc. (CNTX) in their 13F filings, down 2 from Q2 2025. 6 opened new positions and 7 sold out. The largest holders were MPM Bioimpact LLC ($14.2M), Avidity Partners Management LP ($8.7M) and Nextech Invest Ltd. ($7.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Context Therapeutics Inc.
- CUSIP
- 21077P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $273K |
| Exits | 7 | $709K |
All 13F filers, Q2 2025 → Q3 2025: 1,978,153 shares bought and 1,616,467 shares sold, net +361,686 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| MPM Bioimpact LLC | 2.33% | No change | 14,705,882 | $14.2M |
| Avidity Partners Management LP | 1.98% | Add +20.1% | 8,981,855 | $8.7M |
| Nextech Invest Ltd. | 1.09% | No change | 7,419,355 | $7.2M |
| Deep Track Capital, LP | 0.20% | No change | 7,419,355 | $7.2M |
| Blue Owl Capital Holdings LP | 2.24% | No change | 7,407,906 | $7.2M |
| Great Point Partners LLC | 1.89% | No change | 4,683,711 | $4.5M |
| Franklin Resources Inc. | 0.00% | No change | 4,003,380 | $3.9M |
| Vanguard Group Inc. | 0.00% | Add +4.0% | 3,495,031 | $3.4M |
| Blackstone Inc. | 0.01% | No change | 2,440,330 | $2.4M |
| Alyeska Investment Group, L.P. | 0.00% | No change | 1,663,355 | $1.6M |
| Nantahala Capital Management, LLC | 0.10% | Reduce -14.1% | 1,661,950 | $1.6M |
| Sio Capital Management, LLC | 0.33% | No change | 1,341,636 | $1.3M |
| BlackRock, Inc. | 0.00% | No change | 848,970 | $822K |
| Geode Capital Management, LLC | 0.00% | Reduce -4.6% | 608,577 | $590K |
| Affinity Asset Advisors, LLC | 0.04% | Reduce -22.3% | 402,653 | $390K |
| ADAR1 Capital Management, LLC | 0.03% | No change | 351,094 | $340K |
| Renaissance Technologies | 0.00% | Reduce -12.0% | 320,127 | $310K |
| State Street Corp. | 0.00% | No change | 152,607 | $148K |
| Walleye Capital LLC | 0.00% | No change | 132,786 | $129K |
| HighTower Advisors, LLC | 0.00% | No change | 125,852 | $122K |
| Pathstone Holdings, LLC | 0.00% | New | 110,244 | $107K |
| Mill Creek Capital Advisors, LLC | 0.00% | No change | 104,631 | $101K |
| Citadel Advisors | 0.00% | New | 103,363 | $100K |
| Velan Capital Investment Management LP | 0.09% | No change | 100,000 | $97K |
| Clear Harbor Asset Management, LLC | 0.01% | Add +60.5% | 92,804 | $90K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -23.1% | 82,111 | $80K |
| Northern Trust Corp. | 0.00% | Reduce -41.5% | 66,384 | $64K |
| Marshall Wace, LLP | 0.00% | New | 35,750 | $35K |
| Osaic Holdings, Inc. | 0.00% | Add +142.9% | 25,500 | $25K |
| Susquehanna International Group, LLP | 0.00% | New | 21,967 | $21K |
| Cerity Partners LLC | 0.00% | No change | 20,000 | $19K |
| Caxton Corp. | 0.08% | No change | 18,403 | $18K |
| XTX Topco Ltd | 0.00% | New | 10,597 | $10K |
| UBS Group AG | 0.00% | Add +1895.1% | 7,382 | $7K |
| Bank of America Corp. | 0.00% | Reduce -20.1% | 434 | $420 |
| Barclays PLC | 0.00% | New | 167 | $162 |
| SBI Securities Co., Ltd. | 0.00% | Add +3.5% | 117 | $113 |
"% of holder's portfolio" is CNTX's weight in each manager's 13F, not the share of Context Therapeutics Inc. the manager owns.